Financial Performance - For the three months ended October 31, 2021, the revenue from continuing operations was HKD 50,902,000, representing a 63.5% increase compared to HKD 31,180,000 for the same period in 2020[8]. - The gross profit for the six months ended October 31, 2021, was HKD 42,501,000, up 34.1% from HKD 31,702,000 in the same period of 2020[8]. - The net loss attributable to owners of the company for the three months ended October 31, 2021, was HKD 17,278,000, a significant improvement from a loss of HKD 45,256,000 in the same period of 2020[8]. - Basic loss per share for the three months ended October 31, 2021, was HKD 0.111, compared to HKD 0.319 for the same period in 2020[10]. - The total comprehensive loss for the six months ended October 31, 2021, was HKD 17,578,000, compared to a loss of HKD 42,196,000 in the same period of 2020[13]. - The company reported a total equity of HKD 535,509 thousand as of October 31, 2021, an increase from HKD 508,888 thousand as of April 30, 2021, representing a growth of 5.2%[23]. - The group reported a net loss of HKD 28,529,000 due to impairment losses for the six months ended October 31, 2021, compared to a loss of HKD 55,415,000 in the same period of 2020[41]. - The group’s net profit attributable to the company's owners from continuing operations was approximately HKD 27,800,000, a significant improvement from a net loss of HKD 45,800,000 in the same period of 2020[83]. Revenue Sources - Total revenue for the three months ended October 31, 2021, was HKD 50,902,000, a 63.3% increase from HKD 31,180,000 in the same period of 2020[37]. - Revenue from construction and building services reached HKD 35,711,000 for the three months ended October 31, 2021, compared to HKD 17,891,000 in the same period of 2020, representing a 99.5% increase[37]. - The lending business generated revenue of HKD 27,643,000 for the six months ended October 31, 2021, up from HKD 24,893,000 in the same period of 2020, marking a 7.0% increase[41]. - The asset management business reported revenue of HKD 1,298,000 for the six months ended October 31, 2021, compared to HKD 789,000 in the same period of 2020, reflecting a 64.5% increase[41]. - The scaffolding and construction services segment generated revenue of approximately HKD 74,600,000, an increase of about HKD 36,800,000 compared to the same period in 2020, due to the awarding of 28 new construction contracts[84]. Expenses and Losses - The company reported other income of HKD 511,000 for the three months ended October 31, 2021, down from HKD 3,829,000 in the same period of 2020[8]. - The operating and administrative expenses for the six months ended October 31, 2021, were HKD 20,955,000, compared to HKD 21,041,000 in the same period of 2020[8]. - The company recorded a loss from other gains and losses of HKD 26,644,000 for the three months ended October 31, 2021, an improvement from a loss of HKD 49,804,000 in the same period of 2020[8]. - Interest expenses for bank loans and overdrafts decreased to HKD 236,000 for the three months ended October 31, 2021, compared to HKD 492,000 in the same period of 2020, representing a decline of 52.0%[50]. - The expected credit loss provision for the period was HKD 28,529,000, down from HKD 48,130,000 in the same period of the previous year, reflecting a reduction of 40.7%[52]. Assets and Liabilities - Non-current assets increased to HKD 331,122 thousand as of October 31, 2021, up from HKD 294,464 thousand as of April 30, 2021, representing a growth of 12.4%[16]. - Current assets rose to HKD 449,599 thousand, compared to HKD 416,601 thousand in the previous period, marking an increase of 7.9%[16]. - Total liabilities increased to HKD 242,515 thousand from HKD 195,378 thousand, reflecting a rise of 24.1%[16]. - The company’s total assets reached HKD 538,206 thousand, an increase from HKD 509,382 thousand, representing a growth of 5.7%[16]. - The group’s total assets as of October 31, 2021, were approximately HKD 780,700,000, an increase of 9.8% from HKD 711,100,000 as of April 30, 2021[112]. Cash Flow and Financing - The company's net cash flow from operating activities was a negative HKD 29,276 thousand for the six months ended October 31, 2021, compared to a negative HKD 21,378 thousand in the same period last year[28]. - Cash and cash equivalents decreased to HKD 6,746 thousand as of October 31, 2021, down from HKD 53,227 thousand a year earlier, a decline of 87.3%[31]. - The group’s net current assets were approximately HKD 207,100,000 as of October 31, 2021, a decrease of 3.7% from HKD 214,900,000 as of April 30, 2021[112]. - The group issued bonds totaling HKD 20,000,000 with an interest rate of 6.5% on June 4, 2021, and HKD 5,000,000 with an interest rate of 11% on August 19, 2021[113]. - The company’s borrowings included new bank loans of HKD 69,328 thousand during the period, compared to HKD 12,668 thousand in the previous year[30]. Strategic Initiatives - The company aims to enhance its market presence and explore new strategies for growth in the upcoming periods[8]. - Future product development and technological advancements are expected to be a focus area for the company to drive revenue growth[8]. - The company is exploring strategic cooperation with Zhejiang Hengtian Biotechnology Co., Ltd. to develop a health industry ecosystem[108]. - The company plans to adjust its asset structure and business strategy to respond to future uncertainties[102]. - The company aims to diversify its business scope and actively seek suitable investment opportunities[103]. Corporate Governance - The audit committee, consisting of three independent non-executive directors, reviewed the company's interim results for the six months ending October 31, 2021, and found them compliant with applicable accounting standards and legal requirements[138]. - The company has adhered to the corporate governance code as per GEM listing rules, with some deviations noted regarding the chairman's meetings with non-executive directors[137]. - The company has maintained the required public float according to GEM listing rules as of the report date[135].
汇隆控股(08021) - 2022 - 中期财报